Shareholding disclosure

Remo und Manuela Stoffel

Declared position

10.63%

Threshold

Crossed upwards

Timeline

Published

30.03.2017

Transaction

22.03.2017

Voting rights breakdown

Voting rights acquired10.63%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAH3R00060

Beneficial owner

Remo und Manuela Stoffel

Declared address

Remo und Manuela Stoffel, 7000 Chur

Fusion / Umstrukturierung

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Remo und Manuela Stoffel

Vifor Pharma AG30.03.2017TAH3R00060

Disclosure summary

Remo und Manuela Stoffel disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 30.03.2017, at 10.63% of voting rights. Notice category: Single shareholder.

Disclosed position

10.63%

Voting rights acquired

Voting rights acquired10.63%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Remo und Manuela Stoffel disclosed a holding in Vifor Pharma AG, published on 30.03.2017.

Publication date30.03.2017

Transaction date22.03.2017

Issuing companyVifor Pharma AG

Beneficial ownerRemo und Manuela Stoffel

Declared addressRemo und Manuela Stoffel, 7000 Chur

CategorySingle shareholder

Voting rights acquired10.63%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAH3R00060

Conditions

Fusion / Umstrukturierung

Source: SIX Exchange Regulation · Publication date: 30.03.2017

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open